Eagle Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-606,597
Closed -$5.22M 562
2023
Q4
$5.22M Sell
606,597
-2,993
-0.5% -$21.9K 0.03% 363
2023
Q3
$4.23M Sell
609,590
-14,529
-2% -$87.7K 0.03% 374
2023
Q2
$3.59M Sell
624,119
-12,355
-2% -$79.9K 0.02% 393
2023
Q1
$4.05M Buy
636,474
+8,940
+1% +$85.3K 0.02% 367
2022
Q4
$7.29M Sell
627,534
-24,990
-4% -$304K 0.04% 276
2022
Q3
$7.72M Sell
652,524
-100,679
-13% -$1.47M 0.05% 275
2022
Q2
$8.59M Buy
753,203
+7,546
+1% +$79.6K 0.05% 265
2022
Q1
$8.37M Buy
745,657
+62,521
+9% +$563K 0.04% 302
2021
Q4
$9.6M Buy
+683,136
New +$12M 0.04% 316

Other funds holding ALHC

Eagle Asset Management's ALHC Position: Q1 2024 in Review

Eagle Asset Management sold out of Alignment Healthcare (ALHC) in Q1 2024, closing a stake of 606,597 shares — an estimated $5.22M sold.

Eagle Asset Management first reported a position in ALHC in Q4 2021 and held it in 9 quarters. The position peaked at $9.6M in Q4 2021. 130 funds tracked by Wall St. Rank hold ALHC as of Q1 2024.

  • Eagle Asset Management reported no remaining Alignment Healthcare position as of Q1 2024 after selling out during the quarter.
  • Eagle Asset Management sold 606,597 Alignment Healthcare shares in Q1 2024, an estimated $5.22M.
  • Eagle Asset Management first reported a position in Alignment Healthcare in Q4 2021 and held it in 9 quarters.
  • Eagle Asset Management's Alignment Healthcare position peaked at $9.6M in Q4 2021.
  • 130 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2024.

Based on Eagle Asset Management's 13F filing for Q1 2024, filed 9 May 2024.